RxDoctor Payments Data

Shahbaz Farnad, MD

Interventional Pain Medicine · Los Angeles, CANPI 1992080618

Payments from drug & device makers

$344in general payments, 2019–2025

Across 15 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$71
  • Kls-martin L.p.$56
  • Galderma Laboratories, L.p.$56
  • Cochlear Americas$46
  • Bioventus LLC$27
  • Medline Industries LP$25
  • plus $63 from 3 others

What the payments were for

  • Food & beverage$344100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$344 in reported general payments places this provider in the 20th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California

Medicare billing

Part B allowed, 2024
$24,722
Medicare patients
65
Services billed
610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →